5-70925108-C-G
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM5PP5_Very_Strong
The NM_000344.4(SMN1):c.5C>G(p.Ala2Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A2V) has been classified as Pathogenic.
Frequency
Consequence
NM_000344.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00455 AC: 8AN: 1760Hom.: 0 Cov.: 0
GnomAD4 exome AF: 0.000617 AC: 26AN: 42172Hom.: 0 Cov.: 0 AF XY: 0.000404 AC XY: 9AN XY: 22260
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00508 AC: 9AN: 1770Hom.: 0 Cov.: 0 AF XY: 0.00775 AC XY: 6AN XY: 774
ClinVar
Submissions by phenotype
Kugelberg-Welander disease Pathogenic:2
- -
- -
Spinal muscular atrophy Pathogenic:1
Variant summary: SMN1 c.5C>G (p.Ala2Gly) results in a non-conservative amino acid change in the encoded protein sequence. Four of four in-silico tools predict a damaging effect of the variant on protein function. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. c.5C>G has been reported in the literature in multiple individuals affected with Spinal Muscular Atrophy (e.g. Mendonca_2020). These data indicate that the variant is very likely to be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 33062891). ClinVar contains an entry for this variant (Variation ID: 9168). Based on the evidence outlined above, the variant was classified as pathogenic. -
Spinal muscular atrophy, type II Pathogenic:1
- -
not provided Pathogenic:1
Frequency data for this variant in the Genome Aggregation Database (gnomAD) cannot be distinguished from that of the SMN2 gene, and is therefore uninformative in assessment of variant pathogenicity (Genome Aggregation Database (gnomAD), Cambridge, MA (URL: http://gnomad.broadinstitute.org)). This variant has been identified in multiple individuals with SMA types II, III, or IV who also carried a heterozygous pathogenic deletion of exon 7 in the SMN1 gene. Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 12515823) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at